For more information or confidential assistance
800-306-3180
se habla español

Stephanie Reid

Stephanie Reid is a practicing attorney and writer. In her position as a staff writer for Drug Reporter, she is dedicated to raising consumer awareness about the dangers of both prescription and common over-the-counter products.

Government Office Expresses Concern With FDA Drug Oversight

The federal Food and Drug Administration (FDA) is tasked with the tremendous responsibility of keeping American consumers safe from dangerous drugs and medical devices. Accordingly, the agency has not only implemented strict pre-market testing and screening measures for new products, but it is required to monitor the products after their... Read more »

Invokana Lawsuit Filed in Alabama District Court

The drug Invokana belongs to a class of Type II diabetes medications known as sodium-glucose cotransporter-2 (SGLT2) inhibitors, and is referred to generically as canagliflozin. This class of drugs, which also includes well-known brands like Farxiga, Xigdua XR, Jardiance and Glyxambi, was once highly-touted as an innovative alternative for Type II... Read more »

Several Claims Added to Xarelto MDL

On December 2, 2015, six additional claimants added their causes of action to the pending multidistrict litigation (MDL) involving the blood-thinning drug Xarelto. Xarelto, which is also known rivaroxaban, is a relatively new blood thinning drug touted to offer patients an increased level of convenience as they treat their underlying... Read more »

Zofran Lawsuit Alleges Drug Causes “Devastating, Irreversible, and Life-Long Consequences”

For many women, the hormonal fluctuations associated with pregnancy bring about unrelenting symptoms including nausea, vomiting and lightheadedness. In the most extreme cases, these women experience a condition known as hyperemesis gravidarum – which can cause dehydration and electrolyte imbalance. For years, doctors and healthcare professionals have prescribed a drug... Read more »